• Company
    • About
    • Team
  • Clinical Need
  • Technology
  • Pipeline
  • Publications
  • News
  • Contact
  • Careers
Skip to content
PolyActiva
  • About
  • Careers
  • Clinical Need
  • Contact
  • Home
  • News
  • Pipeline
  • Privacy Policy
  • Publications
  • Team
  • Technology
  • Terms of Use

    • Positive Phase IIa results in glaucoma trial with low dose cohort

    • Post author:Xandergoulsbra
    • Post published:March 17, 2022
    • Post category:News

    PolyActiva announces positive Phase IIa results in glaucoma trial with low dose cohort.

    Continue ReadingPositive Phase IIa results in glaucoma trial with low dose cohort
    • Go to the previous page
    • 1
    • 2

    Recent Posts

    • PolyActiva and RareSight Form Strategic Collaboration to Develop Breakthrough Treatments for Rare Pediatric Retinal Diseases
    • PolyActiva presents advancements in next-generation ocular micro-implant technology at Eyecelerator @ AAO 2025
    • First patient enrolled in PolyActiva’s Phase 2b clinical trial
    • PolyActiva expands Executive Team to drive transformational growth and advance late-stage clinical development in the US
    • Jerry St. Peter appointed as new PolyActiva CEO and Board Director

    Recent Comments

    No comments to show.

    PolyActiva Pty Ltd

    Unit 21, 45-47 Normanby Road,
    Notting Hill VIC 3168, Australia

    © 2025 PolyActiva. All Rights Reserved. Caution: PolyActiva products are not for sale in the US

    • Privacy Policy
    • Terms of Use